Aquestive Therapeutics (AQST) FCF Margin Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 74.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -247.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 546.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -209.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -522.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 828.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 301.00 |
| 10 | Aquestive Therapeutics | 462.24 Mn | 462.24 Mn | 13.47 Mn | 16,704.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,704.00 |
| Dec 31, 2025 | 8,232.00 |
| Sep 30, 2025 | -1,412.00 |
| Jun 30, 2025 | -4,388.00 |
| Mar 31, 2025 | -18,350.00 |
| Dec 31, 2024 | -2,601.00 |
| Sep 30, 2024 | -6,851.00 |
| Jun 30, 2024 | 3,124.00 |
| Mar 31, 2024 | -16,556.00 |
| Dec 31, 2023 | -10,855.00 |
| Sep 30, 2023 | -4,182.00 |
| Jun 30, 2023 | 2,453.00 |
| Mar 31, 2023 | 19,804.00 |
| Dec 31, 2022 | 15,612.00 |
| Sep 30, 2022 | 9,146.00 |
| Jun 30, 2022 | 701.00 |
| Mar 31, 2022 | 5,862.00 |
| Dec 31, 2021 | 9,427.00 |
| Sep 30, 2021 | 3,554.00 |
| Jun 30, 2021 | 2,886.00 |